Cipla joins hands with Novartis Pharma AG to market diabetes drug Galvus in India Ruchika Sharma10 April 2023 3:10 PM ISTGalvus is one of the leading brands in the Dipeptidyl Peptidase-4 (DPP4) space and amongst the prominent brands in the oral diabetic medication...
Vikas Vij appointed as new CEO of IOL Chemicals and Pharma Ruchika Sharma5 April 2023 2:31 PM ISTMr Vikas Vij takes over from Dr Sanjay Chaturvedi.
Cipla, Aurobindo, Viatris in licensing pact with MPP to produce generic versions of ViiV Healthcare HIV drug Ruchika Sharma31 March 2023 3:09 PM ISTAurobindo and Viatris will manufacture in India; Cipla will manufacture in India and has plans to manufacture in South Africa as well.
Cipla to sell 51 percent stake in Uganda arm for USD 25-30 million Ruchika Sharma15 March 2023 4:00 PM ISTMumbai: Pharma major Cipla Limited and its wholly owned subsidiaries, Cipla (EU) Limited, UK and Meditab Holdings Limited, Mauritius, have entered...
USFDA inspection: Cipla gets 8 observations for Pithampur facility Ruchika Sharma20 Feb 2023 12:15 PM ISTMumbai: Cipla has recently announced that the United States Food and Drug Administration (USFDA) has issued 8 inspectional observations in Form 483...
NPPA Fixes Retail Price Of 18 Formulations, Details Susmita Roy3 Feb 2023 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Cipla net profit rises 7 percent to Rs 808 crore in Q3 Ruchika Sharma28 Jan 2023 10:15 AM ISTNew Delhi: Drug major Cipla on Wednesday reported a 7 percent increase in its consolidated net profit to Rs 808 crore for the third quarter ended...
CDSCO Drug Alert: 70 drug samples including GSK Betnovate C cream, Cipla's Junior Lanzol mentioned in the list Susmita Roy21 Jan 2023 1:08 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 70 medicine...
CDSCO Panel allows Cipla to waive requirements for phase 4 study of tocilizumab inj for giant cell arthritis Dr. Divya Colin19 Jan 2023 6:00 PM ISTNew Delhi: Considering that Giant Cell Arthritis is very rare disease and there is challenge in recruitment of patients, the Subject Export Committee...
NPPA Fixes Retail Price Of 36 Formulations, Details Dr. Divya Colin11 Jan 2023 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, the Government of...
Continued pricing pressures in US, European Markets to affect profit margins of Indian pharma firms: Ratings agency ICRA Ruchika Sharma6 Jan 2023 2:30 PM ISTICRA said most major Indian pharmaceutical companies continue to focus on emerging markets to fuel their growth, given that they continue to face...
Cipla UK subsidiary to infuse EUR 15 million in Ethris Ruchika Sharma30 Dec 2022 11:32 AM ISTMumbai: Cipla Limited has announced that its wholly-owned UKsubsidiary, Cipla (EU) Limited has signed definitive agreements for equityinvestment of...
